Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728117 · ClinicalTrials.gov registry record · NA
Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT00728117 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 177 participants.
The verdict
NCT00728117, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
We hypothesize that feeding preterm infants while they receive indomethacin or ibuprofen therapy for treatment of a patent ductus arteriosus will decrease the incidence of feeding intolerance and shorten the time period that infants need to tolerate full enteral nutrition. We also hypothesize that this intervention will minimize the alterations in intestinal permeability that occur with these drugs and will improve the infants' hemodynamic response to enteral nutrition
Interventions
- OTHER feeding
- OTHER fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728117
The ClinicalTrials.gov registry entry for NCT00728117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which feeding is the first listed.
NCT00728117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00728117 about?
NCT00728117 is a clinical study titled "Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants". We hypothesize that feeding preterm infants while they receive indomethacin or ibuprofen therapy for treatment of a patent ductus arteriosus will decrease the incidence of feeding intolerance and shorten the time period that infants need to tolerate full enteral nutrition. We also hypothesize that t...
What is the current status of trial NCT00728117?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2008-07. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00728117?
The interventions under investigation include: feeding (OTHER), fasting (OTHER).
Who is sponsoring clinical trial NCT00728117?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.